Suggestions
Ameya Phadke, Ph.D.
Leading a patient solutions business in a tech-enabled pharma sector
Ameya Phadke is a results-driven and creative team player with expertise in both commercial and technical aspects in life sciences and medical devices. With a background in business strategy, strategic marketing, and R&D, Ameya excels in agile teams and is skilled at communicating complex concepts to various audiences. They hold educational qualifications from Loyola High School, University of Pennsylvania, Massachusetts Institute of Technology, and University of California, San Diego. Ameya has experience as a mentor at MassChallenge HealthTech and has worked as a Senior Manager in Technology Partnerships at Chiesi Group.
Highlights
Incredibly eloquent article on how, despite all of this talk of new miracle drugs, we have had one at our disposal the whole time: behavior change.
Despite transient (and perhaps fickle) trends holding back digital therapeutics, I am maintaining my long term view that these solutions are a never-seen before opportunity to productize behavior change more scalable than we’ve ever been able to.
Launching a prescription DTx as a pharma core business & country team;
A detailed (and uniquely transparent!) interview from Lena Offermann, our colleague from Chiesi Deutschland team that is running the commercialization of Kaia Health's Kaia COPD as part of our partnership with them. Yet another proof point that this partnership goes way beyond innovation theater for us, and is about real action by our core business- and at a time where the overall theme in digital therapeutics is all "doom and gloom", this serves as a reminder that regardless of market & investor sentiment, patient needs still need to be met.
This, along with our previous article on this history of this partnership will hopefully provide the detailed journey from partnership through launch of a DTx from the Pharma perspective.
To use what is now becoming a call to action with colleagues, the Chiesi Group team (and the Chiesi Deutschland team in particular) have accomplished 10 years worth of DTx learnings in less than 3 years. Proud to have been working with Lena Offermann and the rest of the team to bring meaningful change to the industry. They have also built a wonderful collaborative relationship with Dennis Hermann, Arabella Grandel, Ronald Graefe and the rest of the team at Kaia Health to approach this as a partnership between two equals!
#digitaltherapeutics #pharma #diga #copd #respiratory
